跳至主要内容
临床试验/NCT00861237
NCT00861237终止4 期

Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
12
试验地点
1
主要终点
Frequency of atrial fibrillation after heart surgery with heart lung machine

研究概览

简要总结

After heart surgery, about 30% of patients suffer from atrial fibrillation. Patients are randomized into two groups receiving either potentized Strychnos Nux vomica or placebo under double blind conditions. Postoperatively, ECGs are done to monitor cardiac rhythm.

详细描述

Preoperatively, patients receive potentized Nux vomica or placebo sublingually. Then, patients are observed regarding atrial fibrillation postsurgical. The difference between the group of patients with and without nux vomica is recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients before elective Heart valve - or aortocoronary by pass surgery with heart-lung-machine.

排除标准

  • Pregnant patients
  • Patients with preoperative atrial fibrillation and/or hyperthyreosis

研究组 & 干预措施

Placebo globules group

Placebo Comparator

Patients receive Placebo globules made out of sugar and looking similar to active drug sublingually before surgery.

干预措施: Placebo (placebo comparator) (Drug)

Nux vomica group

Active Comparator

Patients receive Nux vomica globules made out of sugar sublingually before surgery.

干预措施: Nux vomica (active comparator) (Drug)

结局指标

主要结局

Frequency of atrial fibrillation after heart surgery with heart lung machine

时间窗: 24 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Frass

Prof. Dr.

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验